NEW YORK, NY — As the sun sets on October 13, 2026, the global skyline will undergo a dramatic transformation. From the towering heights of One World Trade Center in New York to the historic Ness Bridge in the Scottish Highlands, more than 325 landmarks across 20 countries and all 50 U.S. states will illuminate in a synchronized display of teal, green, and pink. This vibrant spectacle marks the pinnacle of the #LightUpMBC campaign, an international initiative spearheaded by METAvivor Research and Support to bring visibility to Metastatic Breast Cancer (MBC), the only form of breast cancer that is currently incurable.
Now in its ninth year, the campaign has evolved from a localized tribute into a massive advocacy movement, aiming to redirect the narrative of Breast Cancer Awareness Month toward the harsh realities of Stage 4 disease and the critical need for life-extending research.
Main Facts: A Global Call to Action
The #LightUpMBC campaign serves as the centerpiece for National Metastatic Breast Cancer Awareness Day. While traditional breast cancer awareness often focuses on early detection and "survivorship" milestones, METAvivor’s initiative highlights the estimated 168,000 Americans currently living with metastatic disease—a condition where the cancer has spread beyond the breast to vital organs such as the bones, liver, lungs, or brain.
The 2026 campaign is set to be the largest in the organization’s history. Participating landmarks include architectural icons such as the Willis Tower in Chicago, Philadelphia City Hall, and the Mactan-Cebu International Airport in the Philippines. These structures will glow in the specific MBC awareness colors: teal for healing and spirituality, green for the triumph of spring over winter (symbolizing renewal), and pink for the breast cancer origins of the disease.
The campaign’s primary objective is twofold: to provide a visual memorial for the lives lost to MBC and to raise funds for the research necessary to transition the disease from a terminal diagnosis to a manageable, chronic condition. To date, the #LightUpMBC movement has raised over $2.7 million, with 100% of net proceeds going directly to scientific research grants.
Chronology: From a Single Bridge to a Global Network
The origins of #LightUpMBC are rooted in personal loss and a singular wish. In 2017, the campaign was founded by Laura Inahara in honor of her best friend, Jessica Moore, who was diagnosed with MBC at the age of 32 and passed away just four years later. Moore’s simple hope was to see a single local landmark lit in MBC colors to acknowledge those often forgotten by mainstream "pink" campaigns.
- 2017: The Memorial Bridge in Portsmouth, New Hampshire, becomes the first landmark to light up for MBC.
- 2018–2020: The campaign gains traction across the Northeast United States, evolving into a digital movement as patient advocates use social media to lobby city councils and building managers.
- 2021: Despite the challenges of the global pandemic, the first #LightUpMBC Live virtual broadcast is launched, connecting patients globally.
- 2023–2025: The campaign expands significantly into Europe, Asia, and South America, with landmarks in over 15 countries participating.
- 2026: The movement reaches a record-breaking 325+ landmarks and incorporates a high-production-value livestream featuring Broadway stars and world-renowned scientists.
"Jessica hoped to illuminate one local landmark," said Laura Inahara, #LightUpMBC Founder. "Today, her legacy helps families around the world shine a light for the people they love and has raised millions for critical research."
Supporting Data: The Stark Reality of MBC in 2026
Despite advances in oncology, the statistics surrounding metastatic breast cancer remain sobering. According to data from the National Cancer Institute (NCI) and SEER (Surveillance, Epidemiology, and End Results) program, approximately 42,670 people in the United States are expected to die from breast cancer in 2026. This equates to roughly 117 deaths every single day.
Crucially, nearly all deaths attributed to breast cancer are the result of metastasis. While the five-year survival rate for localized breast cancer is nearly 99%, that figure drops precipitously to approximately 30% once the disease becomes metastatic.
Furthermore, a persistent "funding gap" exists in the research community. Historical data suggests that while billions are raised for breast cancer annually, only an estimated 7% to 10% of those funds are traditionally allocated to researching metastatic disease. METAvivor was founded specifically to address this disparity, exclusively funding Stage 4 research. The organization utilizes a rigorous peer-review process where both scientific experts and patient advocates evaluate grant applications, ensuring that the research funded has the highest potential for immediate patient impact.
Official Responses: Leadership and Advocacy
The leadership at METAvivor emphasizes that the campaign is more than just a visual display; it is a lifeline for a community that often feels invisible during the "pink-washed" month of October.
Dr. Kelly Shanahan, METAvivor Board President and a physician living with MBC since 2013, highlighted the personal stakes of the movement. "When I was diagnosed, I certainly didn’t think I’d still be here 13 years later," Dr. Shanahan remarked. "My hope, and the hope of so many others, lies in research. #LightUpMBC is the biggest contributor to this research and is also a way to bring us together as a community."
Tami Eagle Bowling, the campaign’s Director and a 11-year MBC survivor, will co-host the #LightUpMBC Live broadcast. "This program is about meeting the people behind the lights," Bowling stated. "We are bringing together patient stories from the very landmarks that are being illuminated, bridging the gap between the scientific community and the families who are fighting for more time."
The broadcast will also feature a prestigious lineup of performers, including two-time Tony Award winner Victoria Clark and Tony Award nominee Dorian Harewood, underscoring the broad cultural support for the cause.
Implications: Reshaping the Future of Oncology
The #LightUpMBC campaign represents a broader shift in how society views and treats terminal illness. By focusing on "Action over Awareness," METAvivor is driving a paradigm shift in the oncology field:
1. The Transition to Chronic Disease Management
The ultimate goal of the research funded by this campaign is to transform MBC into a "survivable condition." Much like the medical community’s approach to HIV/AIDS or Type 1 Diabetes, the focus is shifting toward long-term disease stability and maintaining a high quality of life through a rotating sequence of therapies.
2. Empowering the Patient-Advocate Model
METAvivor’s model—where patients help decide which research projects receive funding—is becoming a blueprint for other disease-specific nonprofits. This ensures that research is not just scientifically sound but also addresses the practical needs of those living with the disease, such as reducing toxicity in treatments and managing brain metastases.
3. Global Solidarity and Policy Influence
The international scale of the 2026 campaign exerts pressure on global health bodies to standardize MBC data collection and improve access to clinical trials. When 20 countries light up in unison, it sends a powerful message to policymakers that the metastatic community is a organized, global constituency.
4. Challenging the "Cure" Narrative
The campaign forces a public reckoning with the limitations of current medical technology. By acknowledging that there is currently no cure, #LightUpMBC fosters a more honest dialogue about the end-of-life care, the financial toxicity of lifelong treatment, and the psychological toll of living "scan to scan."
Conclusion: How to Participate
The public is encouraged to participate in the 2026 event by visiting local landmarks on the night of October 13 and sharing photographs on social media using the hashtags #LightUpMBC and #METAvivor.
For those unable to visit a landmark in person, #LightUpMBC Live will stream for free at 8 p.m. ET / 5 p.m. PT on the METAvivor YouTube and Facebook channels, as well as through LiveOne. The broadcast promises a mix of scientific education, emotional storytelling, and world-class musical performances.
As the lights dim on the morning of October 14, the work of METAvivor will continue. With 100% of the campaign’s proceeds fueling the next generation of clinical trials and molecular research, the hope is that one day, the lights will shine not just for awareness, but in celebration of a definitive end to the lethality of breast cancer.
For more information, a full list of participating landmarks, or to make a donation, visit www.lightupmbc.org.
About the Author
